WuXi PharmaTech Schedules Third-Quarter 2013 Earnings Release
Source: prnewswire.com View: 264 Date: 2013-10-15

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the third quarter of 2013 after the New York Stock Exchange closes on Tuesday, November 12, 2013 (which will be Wednesday morning, November 13, 2013 Shanghai time). The earnings release will be available on the investor relations section of the Company’s website at http://www.wuxiapptec.com/.

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 9:00 pm (Beijing/Shanghai/Hong Kong) on Wednesday, November 13, 2013, to discuss the third-quarter 2013 financial results and recent business activities. The conference call may be accessed by calling:

China 4001 200 539
Hong Kong 800 905 927
Singapore 800 616 3222
United Kingdom 0800 015 9725
United States 1855 298 3404
United States—New York (toll) +1 631 5142 526
Other countries (toll) +65 6823 2299
Conference ID 5522969

A telephone replay will be available two hours after the call’s completion at:

China 4001 842 240
Hong Kong 800 966 697
Singapore 800 616 2127
United Kingdom 0800 169 7301
United States 1866 846 0868
Conference ID 5522969

A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech’s website at http://www.wuxiapptec.com/.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech’s services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

For more information, please contact:

Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com
Web: http://www.wuxiapptec.com

SOURCE WuXi PharmaTech (Cayman) Inc.


Devott Publications
The Selection of the TOP Global Outsourcing Destinations – China TOP 15 (TGOD China TOP 15) Ended and Its Rankings and Research Reports are Now Available Worldwide